Prognostic stratification in early-stage hepatocellular carcinoma: Imaging biomarkers are needed
Liver Int
.
2024 Apr;44(4):881-883.
doi: 10.1111/liv.15869.
Authors
Jérémy Dana
1
2
3
4
,
Olivier Sutter
5
6
Affiliations
1
Department of Diagnostic Radiology, McGill University Health Centre, Montreal, Quebec, Canada.
2
Augmented Intelligence & Precision Health Laboratory (AIPHL), McGill University Health Centre Research Institute, Montreal, Quebec, Canada.
3
Institut Hospitalo-Universitaire (IHU) Strasbourg, Université de Strasbourg, Strasbourg, France.
4
Inserm U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Université de Strasbourg, Strasbourg, France.
5
Interventional Radiology Unit, Hôpital Avicenne, Hôpitaux Universitaires Paris Seine-Saint-Denis, APHP, Bobigny, France.
6
Team MONC, Inria, CNRS UMR 5251, Bordeaux INP, Université de Bordeaux, Bordeaux, France.
PMID:
38517296
DOI:
10.1111/liv.15869
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biomarkers, Tumor
Carcinoma, Hepatocellular* / diagnostic imaging
Diagnostic Imaging
Humans
Liver Neoplasms* / diagnostic imaging
Prognosis
Substances
Biomarkers, Tumor